Anthony M. Manning

Molecular Biology · 2001–2013

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 11 citations into it

Whom Anthony M. Manning trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Davis

Who trusts Anthony M. Manning overall

1. P. Roberts

Papers from Anthony M. Manning's perspective

Ordered by how strongly the researchers Anthony M. Manning trusts endorse each paper. Same corpus, a different order for every researcher.

1. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase (Proceedings of the National Academy of Sciences of the United States of America)
2. The specificities of protein kinase inhibitors: an update. (Biochemical Journal)
3. Blocking oncogenic Ras signaling for cancer therapy. (Journal of the National Cancer Institute)
4. NF-κB: a key role in inflammatory diseases
5. A central role for JNK in obesity and insulin resistance (Nature)
6. Signal transduction by the JNK group of MAP kinases. (Cell)
7. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
8. Overview of the CCP4 suite and current developments
9. A Medicinal Chemist’s Guide to Molecular Interactions
10. Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix (Science)

Their papers

• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase (2001) — 2,662 citations
• Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy (2013) — 609 citations
• Targeting JNK for therapeutic benefit: from junk to gold? (2003) — 621 citations
• c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. (2001) — 817 citations